# Haupt Pharma Amareg GmbH – FDA Inspection, Nov 10, 2017

Source: https://www.keypedia.com/records/fda_inspections/haupt-pharma-amareg-gmbh/ff1d6434-13f7-4c0d-9c4d-3797bdc4ffbc
Source feed: FDA_Inspections

> FDA inspection 1038904 of Haupt Pharma Amareg GmbH, November 10, 2017. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1038904
- Company Name: Haupt Pharma Amareg GmbH
- Inspection Date: 2017-11-10
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1274881 - 2024-07-26](https://www.keypedia.com/records/fda_inspections/haupt-pharma-amareg-gmbh/c2c3b316-3961-4c7b-9293-5fcc6a5dc890)
- FDA Inspection 1134674 - 2019-06-07
- FDA Inspection 986248 - 2016-08-26
- FDA Inspection 857318 - 2013-11-22
- FDA Inspection 727709 - 2011-05-18

## Related Officers

- [Company Rep](https://www.keypedia.com/people/parul-m-patel/2a7e7ff1-6b9b-42d7-8bc4-03eeecc5cecc)

Company: https://www.keypedia.com/companies/haupt-pharma-amareg-gmbh/6badd9f8-b509-4f18-bbcf-4fcd058ba5b3

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c